These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16627032)

  • 21. [Use of contraceptives in Norway in 2005].
    Skjeldestad FE
    Tidsskr Nor Laegeforen; 2007 Nov; 127(21):2803-5. PubMed ID: 17987070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonoxynol-9 vaginal pessary: a preliminary Indian experience.
    Yadav SC; Gaur LN; Gupta N; Roy M; Saxena NC
    Natl Med J India; 2006; 19(3):133-6. PubMed ID: 16836262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lea's Shield contraceptive device: pilot study of its short-term patient acceptability and aspects of use.
    Bounds W; Guillebaud J
    Br J Fam Plann; 1999 Jan; 24(4):117-20. PubMed ID: 10023094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New delivery systems in contraception: vaginal rings.
    Johansson ED; Sitruk-Ware R
    Am J Obstet Gynecol; 2004 Apr; 190(4 Suppl):S54-9. PubMed ID: 15105799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initiation of oral contraceptives--start now!
    Edwards SM; Zieman M; Jones K; Diaz A; Robilotto C; Westhoff C
    J Adolesc Health; 2008 Nov; 43(5):432-6. PubMed ID: 18848670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adolescent and young women's experience with the vaginal ring and oral contraceptive pills.
    Stewart FH; Brown BA; Raine TR; Weitz TA; Harper CC
    J Pediatr Adolesc Gynecol; 2007 Dec; 20(6):345-51. PubMed ID: 18082856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current status of contraceptive vaginal rings].
    Elstein M; Jackson R; Hickling D; Assendorp R
    Contracept Fertil Sex (Paris); 1992 Jan; 20(1):15-9. PubMed ID: 12343624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceptability of the vaginal contraceptive ring among adolescent women.
    Terrell LR; Tanner AE; Hensel DJ; Blythe MJ; Fortenberry JD
    J Pediatr Adolesc Gynecol; 2011 Aug; 24(4):204-10. PubMed ID: 21454109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contraceptive vaginal ring use for women has less adverse metabolic effects than an oral contraceptive.
    Elkind-Hirsch KE; Darensbourg C; Ogden B; Ogden LF; Hindelang P
    Contraception; 2007 Nov; 76(5):348-56. PubMed ID: 17963858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Social, demographic and situational characteristics associated with inconsistent use of oral contraceptives: evidence from France.
    Moreau C; Bouyer J; Gilbert F; Group C; Bajos N
    Perspect Sex Reprod Health; 2006 Dec; 38(4):190-6. PubMed ID: 17162311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New contraceptive methods.
    Plourd DM; Rayburn WF
    J Reprod Med; 2003 Sep; 48(9):665-71. PubMed ID: 14562628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study.
    Leone Roberti Maggiore U; Remorgida V; Scala C; Tafi E; Venturini PL; Ferrero S
    Acta Obstet Gynecol Scand; 2014 Mar; 93(3):239-47. PubMed ID: 24372517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study on sexual behavior of women using 30 microg ethinylestradiol and 3 mg drospirenone oral contraceptive.
    Caruso S; Agnello C; Intelisano G; Farina M; Di Mari L; Sparacino L; Cianci A
    Contraception; 2005 Jul; 72(1):19-23. PubMed ID: 15964287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Same-day initiation of the transdermal hormonal delivery system (contraceptive patch) versus traditional initiation methods.
    Murthy AS; Creinin MD; Harwood B; Schreiber CA
    Contraception; 2005 Nov; 72(5):333-6. PubMed ID: 16246657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The contraceptive vaginal ring: female adolescents' knowledge, attitudes and plans for use.
    Carey AS; Chiappetta L; Tremont K; Murray PJ; Gold MA
    Contraception; 2007 Dec; 76(6):444-50. PubMed ID: 18061702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial.
    Oddsson K; Leifels-Fischer B; de Melo NR; Wiel-Masson D; Benedetto C; Verhoeven CH; Dieben TO
    Contraception; 2005 Mar; 71(3):176-82. PubMed ID: 15722066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive.
    van den Heuvel MW; van Bragt AJ; Alnabawy AK; Kaptein MC
    Contraception; 2005 Sep; 72(3):168-74. PubMed ID: 16102549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trials point to effectiveness of new vaginal ring.
    Contracept Technol Update; 1982 Feb; 3(2):17-8. PubMed ID: 12279158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of "observed start" vs. traditional "Sunday start" on hormonal contraceptive continuation rates after medical abortion.
    Bednarek PH; Nichols MD; Carlson N; Edelman AB; Creinin MD; Truitt S; Jensen JT
    Contraception; 2008 Jul; 78(1):26-30. PubMed ID: 18555814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combined contraceptive vaginal device (NuvaRing): a comprehensive review.
    Sarkar NN
    Eur J Contracept Reprod Health Care; 2005 Jun; 10(2):73-8. PubMed ID: 16147810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.